order,search_terms,results1,exp rheumatoid arthritis/,1061602,exp abatacept/,25943,"(Belatacept or Nulojix or Orencia).ti,ab.",3574,exp adalimumab/,40235,"(Humira or D2E7 Antibody).ti,ab.",1666,exp anakinra/,46517,"(Urine Interleukin 1 Inhibitor or Antril or Kineret or Anakinra).ti,ab.",13258,exp certolizumab pegol/,4509,"(Cimzia or Cimzias).ti,ab.",2610,exp etanercept/,523111,"(Enbrel or TNF Receptor Type II-IgG Fusion Protein or Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein).ti,ab.",26212,"golimumab.ti,ab.",65513,"Simponi.ti,ab.",1614,exp infliximab/,881815,"Remicade.ti,ab.",27716,exp rituximab/,1148317,"(Mabthera or Rituxan or Rituximab CD20 Antibody).ti,ab.",39118,"tocilizumab.ti,ab.",174519,"(atlizumab or Actemra).ti,ab.",4520,"tofacitinib.ti,ab.",48521,"(tasocitinib or tofacitinib citrate or Xeljanz).ti,ab.",3522,sarilumab.mp.,3123,or/2-22,3556724,Randomized Controlled Trials as Topic/,11410725,randomized controlled trial/,46593326,Random Allocation/,9312627,Double Blind Method/,14788928,Single Blind Method/,2476729,clinical trial/,52224830,"clinical trial, phase i.pt.",1886031,"clinical trial, phase ii.pt.",3039832,"clinical trial, phase iii.pt.",1398733,"clinical trial, phase iv.pt.",150034,controlled clinical trial.pt.,9420835,randomized controlled trial.pt.,46593336,multicenter study.pt.,22990337,clinical trial.pt.,52224838,exp Clinical Trials as topic/,31491139,23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37,123713640,(clinical adj trial$).tw.,29511941,((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or mask$3)).tw.,15621042,PLACEBOS/,3501943,placebo$.tw.,19376044,randomly allocated.tw.,2310145,(allocated adj2 random$).tw.,2608346,or/39-44,53909647,38 or 45,144188648,case report.tw.,25715749,letter/,96963850,historical article/,34820251,47 or 48 or 49,156110952,46 not 50,140866953,1 and 22 and 51,227054,limit 52 to english language,2099